Unilateral retinoblastoma, lack of familial history and older age does not exclude germline RB1 gene mutation

被引:31
作者
Brichard, B
Heusterspreute, M
De Potter, P
Chantrain, C
Vermylen, C
Sibille, C
Gala, JL
机构
[1] Catholic Univ Louvain, Clin Univ St Luc, Dept Pediat Haematol & Oncol, B-1200 Brussels, Belgium
[2] Catholic Univ Louvain, Clin Univ St Luc, Ctr Human Genet, B-1200 Brussels, Belgium
[3] Catholic Univ Louvain, Clin Univ St Luc, Dept Ophthalmol, B-1200 Brussels, Belgium
关键词
retinoblastoma; RB1; germline mutation; molecular genetics; mutation screening;
D O I
10.1016/j.ejca.2005.07.027
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Conclusive identification of RB1 mutations in retinoblastoma is predicted to improve the clinical management of affected children and relatives. However, despite clear clinical benefits, RB1 screening remains difficult, most of the alterations being unique and randomly distributed throughout the entire coding sequence. In this report, we present the results of a constitutional RB1 analysis under-taken in our institution over the last four years. The detection of RB1 gene deletion or mutation was performed by Southern blot and sequence analyses in 73 patients (including three families with 2, 3 and 3 probands, respectively). Complementary constitutional chromosome and fluorescent in situ hybridization (FISH) analyses of RB1 gene were applied in cases where hereditary retinoblastoma was suspected despite negative detection. Altogether, germline abnormalities were found in 11% (4/36 patients) of sporadic unilateral retinoblastoma (median age, 21.5 months) and 86% (32/37 patients) of sporadic bilateral or positive familial history retinoblastoma (median age, 5 months). The spectrum of germline alterations found in 31 distinct families included 12 nonsense mutations (39%); 10 point insertions or deletions with frameshift (32%); 4 mutations and 1 deletion affecting splice sites (16%); 2 missense mutations (6%); and 2 large deletions (6%). A total of 15 mutations have not been previously reported. In this small series, splicing mutations were associated with bilateral disease whilst most of the frameshift mutations were identified in patients with an early age at diagnosis, bilateral disease or hereditary forms of the disease. \ This study confirms that screening for constitutional RB1 mutation should become an integral part of current management of any patient affected by retinoblastoma irrespective of the tumour laterality and familial background. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:65 / 72
页数:8
相关论文
共 35 条
[1]   Spectrum of germline RB1 gene mutations in Spanish retinoblastoma patients:: Phenotypic and molecular epidemiological implications [J].
Alonso, J ;
García-Miguel, P ;
Abelairas, J ;
Mendiola, M ;
Sarret, E ;
Vendrell, MT ;
Navajas, A ;
Pestaña, A .
HUMAN MUTATION, 2001, 17 (05) :412-422
[2]  
Ata-ur-Rasheed M, 2002, Ophthalmic Genet, V23, P121, DOI 10.1076/opge.23.2.121.2211
[3]   SPECTRUM OF GERMLINE MUTATIONS IN THE RB1 GENE - A STUDY OF 232 PATIENTS WITH HEREDITARY AND NON HEREDITARY RETINOBLASTOMA [J].
BLANQUET, V ;
TURLEAU, C ;
GROSSMORAND, MS ;
BEAUFORT, CS ;
DOZ, F ;
BESMOND, C .
HUMAN MOLECULAR GENETICS, 1995, 4 (03) :383-388
[4]  
BONAITIPELLIE C, 1975, ANN GENET-PARIS, V18, P223
[5]   Deletion of RB exons 24 and 25 causes low-penetrance retinoblastoma [J].
Bremner, R ;
Du, DC ;
ConnollyWilson, MJ ;
Bridge, P ;
Ahmad, KF ;
Mostachfi, H ;
Rushlow, D ;
Dunn, JM ;
Gallie, BL .
AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (03) :556-570
[6]   RB1 genetic testing as a clinical service:: A follow-up study [J].
Cohen, JG ;
Dryja, TP ;
Davis, KB ;
Diller, LR ;
Li, FP .
MEDICAL AND PEDIATRIC ONCOLOGY, 2001, 37 (04) :372-378
[7]  
Cowell JK, 1998, EUR J CANCER, V34, P1825
[8]  
Cowell John K., 1994, European Journal of Human Genetics, V2, P281
[9]   Detection of mutations in argentine retinoblastoma patients by segregation of polymorphisms, exon analysis and cytogenetic test [J].
Dalamon, V ;
Surace, E ;
Borelina, D ;
Ziembar, M ;
Esperante, S ;
Francipane, L ;
Davila, M ;
Parma, D ;
Szijan, I .
OPHTHALMIC RESEARCH, 2001, 33 (06) :336-339
[10]   Retinoblastoma: the disease, gene and protein provide critical leads to understand cancer [J].
DiCiommo, D ;
Gallie, BL ;
Bremner, R .
SEMINARS IN CANCER BIOLOGY, 2000, 10 (04) :255-269